The Role of Drug Exposure in Clinical Development: To What Extent Is Pharmacokinetic Assessment Needed in a Drug Development Programme? Navin Goyal Commentary 27 May 2015 Pages: 985 - 987
Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer Paul R. Hutson Commentary 16 June 2015 Pages: 989 - 991
Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients Christine E. StaatzSusan E. Tett Review Article 03 June 2015 Pages: 993 - 1025
Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor Damayanthi DevineniDavid Polidori Review Article 04 June 2015 Pages: 1027 - 1041
Clinical Pharmacokinetic Studies of Enzalutamide Jacqueline A. GibbonsTaoufik OuatasJoyce Mordenti Original Research Article Open access 28 April 2015 Pages: 1043 - 1055
Pharmacokinetic Drug Interaction Studies with Enzalutamide Jacqueline A. GibbonsMichiel de VriesTaoufik Ouatas Original Research Article Open access 01 May 2015 Pages: 1057 - 1069
Population Pharmacokinetics of ABT-806, an Investigational Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody, in Advanced Solid Tumor Types Likely to Either Over-Express Wild-Type EGFR or Express Variant III Mutant EGFR Shringi SharmaRajendar K. MittapalliHao Xiong Original Research Article 12 March 2015 Pages: 1071 - 1081
A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose Nieves Velez de MendizabalRicardo Jimenez-MendezBruce C. Carleton Short Communication 13 March 2015 Pages: 1083 - 1090